Liver Cirrhosis, Experimental
Research News and Information

Saturday, November 21, 2009

Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis.

5 Oct 2009 AIM: To investigate the correlation between the antifibrotic effect of baicalin and serum cytokine production in rat hepatic fibrosis. METHODS: Forty male Sprague-Dawley rats were divided randomly into four groups: normal control group, model group, ... Read more...

Angiogenesis and liver fibrogenesis.

29 Sep 2009 Angiogenesis is a dynamic, hypoxia-stimulated and growth factor-dependent process, eventually leading to the formation of new vessels from pre-existing blood vessels. In the last decade experimental and clinical studies have described the occurrence ... Read more...

Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis.

26 Sep 2009 AIM: To investigate the inhibitory effect of natural taurine (NTau) on portal hypertension (PHT) in rats with experimentally-induced liver cirrhosis (LC). METHODS: Experimentally-induced LC Wistar rats (20 rats/group) were treated with either oral ... Read more...

Latest indexed articles for 'Liver Cirrhosis, Experimental'

These are the very latest articles for this heading:

• Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis. 5 Oct 2009
• Angiogenesis and liver fibrogenesis. 29 Sep 2009
• Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis. 26 Sep 2009
• Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. 12 Sep 2009
• Effect of early propranolol administration on portal hypertensive gastropathy in cirrhotic rats. 12 Sep 2009
• Helicobacter pylori promotes hepatic fibrosis in the animal model. 5 Sep 2009
• PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis. 30 Aug 2009
• The bone marrow and liver fibrosis: friend or foe? 27 Aug 2009
• Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways. 8 Aug 2009
• Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. 30 Jul 2009
• Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. 27 Jul 2009
• Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Jul 2009
• Oxidative stress, isoprostanes and hepatic fibrosis. 29 Jun 2009
• CCR1 and CCR5 promote hepatic fibrosis in mice. 29 Jun 2009
• c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. 19 Jun 2009
• Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers. 11 Jun 2009
• Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin. 10 Jun 2009
• Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. 30 May 2009
• Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. 18 May 2009
• Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. 16 May 2009

See a longer list of these articles.

Technical information about 'Liver Cirrhosis, Experimental'

Definition: Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.

Descriptor UI: D008106

Alternative terms: Liver Cirrhosis, Experimental; Cirrhosis, Experimental Liver; Liver Cirrhoses, Experimental; Experimental Liver Cirrhosis; Hepatic Cirrhosis, Experimental; Experimental Hepatic Cirrhosis; Cirrhoses, Experimental Liver; Experimental Liver Cirrhoses;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C06.552.630.467; E05.598.500.468;

Technical Notes: DF: LIVER CIRRHOSIS EXPER